Listing & Compliance Notices

Fintech Ecosystem Development Corp. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5450(b)(3)(A), 5810(c)(3)(C)).

“August 21, 2023, Fintech Ecosystem Development Corp., a Delaware corporation (the “ Company ”), received a written notice (the “ Notice ”) from the Staff of the Listing Qualifications Department (the “ Staff ”) of the Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that, for the last 30 consecutive business days, the Company’s Market Value of Listed Securities (“ MVLS ”) was below the minimum of $50 million required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(b)(2)(A) (the “ Market Value Standard ”). The Staff also noted that the Company d”

Bannix Acquisition Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 22, 2023, Bannix Acquisition Corp., a Delaware corporation (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company has not yet filed its Form 10-Q for the quarter ended June 30, 2023, the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “SEC”). This notification has no immediate effect on the listing of the Company’s shares on Nasdaq. However, if the Company fai”

Cascadia Acquisition Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 18, 2023, Cascadia Acquisition Corp., a Delaware corporation (the “ Company ”) received a written notice (the “ Notice ”) from the Listing Qualifications Staff of the Nasdaq Stock Market (“ Nasdaq ”) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) as it had failed to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023. The Notice has no immediate effect on the listing of the Company’s stock on the Nasdaq Global Market. The Company has until October 2, 2023 to provide Nasdaq with a specific plan to regain compliance wi”

Project Energy Reimagined Acquisition Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 18, 2023, Project Energy Reimagined Acquisition Corp. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) due to a delay in filing its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”). The Rule requires listed companies to timely file all required periodic financial reports with the SEC. The Notice is only a not”

Khosla Ventures Acquisition Co. received a nasdaq deficiency notice notice regarding other (rules 5550(b)(2), 5810(c)(3)(C)).

“August 18, 2023, Khosla Ventures Acquisition Co. (the “Company”) received a letter (the “Nasdaq Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires that the Company’s listed securities maintain a minimum Market Value of Listed Securities (“MVLS”) of $35 million. The Nasdaq Letter further provided that, pursuant to Nasdaq Listing Rule 5810(c)(3)(C), the Company is entitled to a compliance period to regain compliance with Nasdaq Listing Rule 5550(b)”

Ace Global Business Acquisition Ltd received a nasdaq compliance regained notice regarding other (rules 5550(a)(3)).

“August 24, 2023, the Company received a letter from Nasdaq confirming that, based on information submitted by the Company to Nasdaq on August 23, 2023, the Company regained compliance with the Minimum Public Holders Rule. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: August 24, 2023 Ace Global Business Acquisition Limited (Registrant) By: /s/ Eugene Wong Name: Title: Eugene Wong Chief Executive Officer”

TON Strategy Co received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“equity be at least $2,500,000 (the “Stockholders’ Equity Requirement”). As reported in its Form 10-Q, the Company’s stockholders’ equity as of June 30, 2023 was ($1,818,000). The Staff’s notice has no immediate impact on the listing of the Company’s common stock on Nasdaq. In accordance with the Nasdaq Listing Rules, the Company has 45 calendar”

NextPlay Technologies Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“Rule. If the Company fails to file the 10-K and 10-Q with the Commission by November 27, 2023, Nasdaq will provide written notification to the Company that its securities will be delisted. At that time, the Company may appeal the Nasdaq staff’s determination to a Hearings Panel under Nasdaq Listing Rule 5815. The Company currently intends to file its 10-K and 10-Q before the November 27, 2023 deadline. However, there can be no assurance that the Company will be successful in implementing its plan to regain compliance with the Nasdaq Listing Rules, including filing both the 10-K and 10-Q with t”

BIMI Holdings Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“August 22, 2023, BIMI International Medical Inc. (the “Company”) received a notification letter (the “Nasdaq 10-Q Delinquency Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “Form 10-Q”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. The Nasdaq 10-Q Delinquency Letter states that t”

Golden Minerals Co received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(iii)).

“June 6, 2023 that the Company is not in compliance with Section 1003(a)(iii) of the NYSE American Company Guide (the “Company Guide”). The Company is required to report a stockholders’ equity of $6.0 million or more if the Company has reported losses from continuing operations and/or net losses in its five most recent fiscal years. The Company reported stockholders’ equity of $4.1 million as of March 31, 2023, and $5.6 million as of June 30, 2023, and losses from continuing operations and/or net losses in each of its five most recent fiscal years ended December 31, 2022. As a result, the Compa”

Troika Media Group, Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“August 22, 2023, Troika Media Group, Inc. (the “Company”) received a delinquency notification letter from Nasdaq stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) because it had not timely filed its Quarterly Report on Form 10-Q for the quarter ended June 30, 2023 (the “Form 10-Q”). Nasdaq has informed the Company that the Company must submit a plan of compliance (the “Plan”) within sixty (60) days addressing how it intends to regain compliance with Nasdaq’s listing rules or otherwise file the Form 10-Q before the expiration of such sixty (60) day period. The C”

SMITH MIDLAND CORP received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 17, 2023, Smith-Midland Corporation (the “Company”) received a letter from Nasdaq indicating that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all required periodic financial reports with the Securities and Exchange Commission. The required filing in question is the Company’s Quarterly Report in Form 10-Q for the quarterly period ended June 30, 2023 (the “Form 10-Q”). The delay in filing is related to the Company’s transition to a new independent registered accounting firm and is not related to any of the Company’s internal financial”

CalAmp Corp. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1)).

“August 22, 2023, CalAmp Corp. (the “Company”) received a deficiency letter (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s Class A Common Stock (the “Common Stock”) for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on Nasdaq, as set forth in Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Requirement”). The Notice has no immediate impact on the listing of the Company’s common s”

CalAmp Corp. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“August 22, 2023, CalAmp Corp. (the “Company”) received a deficiency letter (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s Class A Common Stock (the “Common Stock”) for the last 30 consecutive business days, the Company is not currently in compliance with the requirement to maintain a minimum bid price of $1.00 per share for continued listing on Nasdaq, as set forth in Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Requirement”). The Notice has no immediate impact on the listing of the Company’s common s”

DP Cap Acquisition Corp I received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).

“August 21, 2023, DP Cap Acquisition Corp. (the “Company”) received a letter (the “Nasdaq Letter”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Company is not in compliance with Nasdaq Listing Rule 5450(b)(2)(A), which requires that the Company’s listed securities maintain a minimum Market Value of Listed Securities (“MVLS”) of $50 million. The Nasdaq Letter further provided that, pursuant to Nasdaq Listing Rule 5810(c)(3)(C), the Company is entitled to a compliance period to regain compliance with Nasdaq Listing Rule 5450(b)(”

Zalatoris II Acquisition Corp received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 22, 2023, Zalatoris II Acquisition Corp. (formerly known as XPAC Acquisition Corp.), a Cayman Islands limited liability company (NASDAQ: XPAX) (the “ Company ”), received a delinquency notification letter (“Notice”) from the Listing Qualifications staff of the Nasdaq Stock Market LLC (“Nasdaq”) due to the Company’s non-compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of the Company’s failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023 (the “Form 10-Q”). The Rule requires listed companies to timely file all required p”

NEXTNRG, INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 22, 2023, EzFill Holdings, Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company’s stockholders’ equity as reported in its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2023 (the “Form 10-Q”), did not satisfy the continued listing requirement under Nasdaq Listing Rule 5550(b)(1), which requires that a listed company’s stockholders’ equity be at least $2,500,000 (the “Stockholders’ Equity Requirement”). As reported in its Form 10-Q, the Company’s stockholders”

Tempo Automation Holdings, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 17, 2023, Tempo Automation Holdings, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the Company has not yet filed its Form 10-Q for the period ended June 30, 2023 (the “Filing”), the Company no longer meets the requirements for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5250(c)(1) (the “Periodic Filing Rule”). The Letter is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trad”

Greenlane Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“August 21, 2023, Greenlane Holdings, Inc. (the “Company”) received a deficiency letter from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the closing bid price for the Company’s Class A common stock, par value $0.01 per share (the “Class A Common Stock”) had been below the minimum $1.00 per share required for continued listing on The Nasdaq Global Market pursuant to Nasdaq Listing Rule 5450(a)(1) (“Rule 5450(a)(1)”). The Nasdaq deficiency letter has no immediate effect”

ADIAL PHARMACEUTICALS, INC. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2), 5550(b)(1)).

“August 7, 2023 to August 18, 2023, the closing bid price of the Company’s common stock has been at $1.00 per share or greater. Accordingly, the Staff has determined that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and that the matter is now closed. On August 22, 2023, the Company also received a notice from the Staff that it now complies with Nasdaq Listing Rule 5550(b)(1), which requires listed companies to maintain stockholders’ equity of at least $2,500,000 and that the matter is now closed. On August 23, 2023, the Company issued a press release announcing that t”

FiEE, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250).

“August 17, 2023, Minim, Inc. (the “Company”) received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company has not filed its Form 10-Q for the period ended June 30, 2023 with the Securities and Exchange Commission (the “Commission”), the Company is not in compliance with Nasdaq’s rules for continued listing under Nasdaq Listing Rule 5250. Rule 5250 requires, in part, that listed companies timely file all required periodic financial reports with the Commission. The non-compliance resulted from the Company’s inability to timely appoint an audit committee to revi”

Orbital Infrastructure Group, Inc. received a nasdaq noncompliance notice notice regarding market value (rules 5550(b)(2)).

“December 28, 2022, the Company was notified by Nasdaq that the market value of its listed securities had been below the $35,000,000 minimum required for continued listing as set forth in Nasdaq Listing Rule 5550(b)(2) for the previous 30 consecutive trading days. In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company was provided 180 calendar days, or until June 26, 2023, to regain compliance with Nasdaq Listing Rule 5550(b)(2). As of the date of this Current Report on Form 8-K, the Company has not regained compliance with Nasdaq Listing Rule 5550(b)(2). The Company’s failure to tim”

Orbital Infrastructure Group, Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“August 18, 2023, Orbital Infrastructure Group, Inc. (the “Company”) was notified by the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), due to its failure to timely file its Quarterly Report on Form 10-Q for the period ended June 30, 2023. As previously disclosed, on December 28, 2022, the Company was notified by Nasdaq that the market value of its listed securities had been below the $35,000,000 minimum required for continued listing as set forth in Nasdaq Listing Rule 5550(b)(2) for the pre”

REPUBLIC FIRST BANCORP INC received a nasdaq noncompliance notice notice regarding late filing.

“August 15, 2023, the Panel has determined to delist the Company’s common stock from trading on The Nasdaq Stock Market LLC (“Nasdaq”) and will suspend trading in the Company’s common stock effective at the open of trading on August 23, 2023. Nasdaq will file a Form 25-NSE with the Securities and Exchange Commission to effect the delisting following the lapse of certain waiting periods set forth in the Nasdaq Listing Rules. The Company anticipates that effective August 23, 2023, the Company’s common stock will commence trading on the OTC Pink marketplace under the symbol “FRBK.” Quotes and rela”

NextTrip, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“andard; Transfer of Listing. On August 17, 2022, Sigma Additive Solutions, Inc. (“we,” “us,” “Sigma” or the “company”) received notice from Nasdaq Listing Qualifications (“Nasdaq”) that because our stockholders’ equity as of June 30, 2023 was $2,391,289, we no longer comply with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on the Nasdaq Capital Market to maintain minimum stockholders’ equity of $2,500,000, and do not meet the alternatives of market value of listed securities or net income from continuing operations. The notice stated that under Nasdaq Rules, we have 45 calen”

TREASURE GLOBAL INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“August 17, 2023, Treasure Global Inc (the “Company”) received a letter from the Nasdaq Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) therein stating that for the 30 consecutive business day period between July 6, 2023 through August 16, 2023, the common stock of the Company had not maintained a minimum closing bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar d”

WeWork Inc. received a nyse delisting notice notice regarding other (rules 802.01D).

“August 22, 2023, the New York Stock Exchange (the “NYSE”) notified WeWork Inc. (the “Company”), and publicly announced, that the NYSE has determined to (A) commence proceedings to delist the Company’s warrant s, each whole warrant exercisable to purchase one share of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), at a price of $11.50 per share, and listed to trade on the NYSE under the symbol “WE WS” (the “Warrants”) and (B) immediately suspend trading in the Warrants due to “abnormally low” trading price levels pursuant to Section 802.01D of the NYSE”

Assure Holdings Corp. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

“July 25, 2023, following the Company’s failure to maintain a minimum closing bid price of $1.00 per share over the previous thirty consecutive business day period (the “Bid Price Deficiency Letter”), in contravention of Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). As previously disclosed, the Company was provided a 180 calendar-day period to regain compliance with the Bid Price Requirement, through January 22, 2024. If the Company does not regain compliance with the Bid Price Requirement by January 22, 2024, the Company would be eligible to request, but may not qualify for, an”

Assure Holdings Corp. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)).

“August 16, 2023, Assure Holdings Corp. (the “Company”) received notice from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company no longer satisfies the $2.5 million stockholders’ equity requirement for continued listing on The Nasdaq Capital Market, or the alternatives to that requirement - a $35 million market value of listed securities or $500,000 in net income in the most recent fiscal year or two or the last three fiscal years - as required by Nasdaq Listing Rule 5550(b) (the “Equity Requirement”). As with the Bid Price Deficiency”

Nixxy, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“On August 17, 2022, the Company received a notification letter from the Nasdaq Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum stockholders’ equity requirements set forth in Nasdaq Listing Rule 5550(b)(1) (the “Minimum Stockholders’ Equity Requirement”) because (i) its stockholders’ equity as reported in its Quarterly Report on Form 10-Q for the period ended June 30, 2023 was not at least $2,500,000 and (ii) the Company does not currently meet the alternatives of market value of listed sec”

COMSovereign Holding Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 18, 2023, the Company received a notice from The Nasdaq Stock Market LLC (“ Nasdaq ”) stating that because the Company has not yet filed the Form 10-K, the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the SEC. On May 17, 2023, the Company received a notice from Nasdaq stating that because the Company has not yet filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rules. On Au”

GT Biopharma, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“August 22, 2023, GT Biopharma, Inc. (the “Company”) received notice from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) advising that the Staff determined the Company is eligible for an additional 180 calendar day period, or until February 20, 2024, to regain compliance with its minimum bid price requirement rule under Rule 5550(a)(2) (the “Minimum Bid Price Requirement”) pursuant to the Nasdaq Listing Rule 5810(c)(3)(A). The notification has no immediate effect on the listing of the Company’s common stock, and its common stock will continu”

URBAN ONE, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1), 12B-25).

“August 16, 2023 (the “Third Nasdaq Letter”) notifying the Company that it was not in compliance with requirements of Nasdaq Listing Rule 5250(c) (1) (the “Rule”) as a result of not having timely filed (i) its Quarterly Report on Form 10-Q for the period ended March 31, 2023 (the “Q1 2023 Form 10-Q” ) and (ii) its Quarterly Report on Form 10-Q for the period ended June 30, 2023 (the “Q2 2023 Form 10-Q” and, together with the Q1 2023 Form 10-Q, the “Delinquent Reports”), with the Securities and Exchange Commission (“SEC”). ​ This notification has no immediate effect on the listing of the Company”

LIFECORE BIOMEDICAL, INC. DE received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“August 17, 2023, Lifecore Biomedical, Inc., a Delaware corporation (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Annual Report on Form 10-K for the period ended May 28, 2023 (the “Form 10-K”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The notification letter has no immediate effect”

EBET, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 15, 2023, the Company received a letter from the Staff, which notified the Company that it does not presently comply with Nasdaq’s Listing Rule 5550(b)(1) (the “Listing Rule”), which requires that the Company maintain a minimum of $2.5 million in stockholders’ equity, and that the Company also does not meet the alternatives of market value of listed securities or net income from continuing operations set forth in the Listing Rule. The letter stated that, in addition to Bid Price Rule deficiency, the Nasdaq Hearings Panel will also consider the non-compliance with the Listing Rule in ren”

EBET, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iii)).

“July 31, 2023, the Company was notified by the Staff that it had determined that the Company’s common stock had a closing bid price of $0.10 or less for ten consecutive trading days from July 17, 2023 through July 28, 2023. Accordingly, since the Company was subject to the provisions set forth under Listing Rule 5810(c)(3)(A)(iii), the Staff had determined to delist the Company’s securities from The Nasdaq Capital Market. The Company submitted a hearing request to Nasdaq’s Hearings Department, which stayed the suspension of the Company’s common stock pending the panel’s decision. The Company’s”

RYTHM, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 16, 2023, the Company received a third notice from Nasdaq that the Company remains noncompliant with the Nasdaq Listing Rule 5250(c)(1) as a result of its failure to file its Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2023 (the “Second Quarter Form 10-Q”) with the SEC by the required filing date (the “August Nasdaq Notice” and, together with the April Nasdaq Notice and the May Nasdaq Notice, the “Nasdaq Notices”). As disclosed in the Current Report on Form 8-K filed by the Company on April 17 , 2023, the Company’s audit committee concluded that, as a result of i”

AKUMIN INC. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1), 5550(b)(2), 5550(b)(3)).

“August 15, 2023, Akumin Inc. (the “Company”) received a written notification (the “Notice”) from the Listing Qualifications Department of the NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with (a) Nasdaq Listing Rule 5550(b)(1) (the “Equity Standard”), pursuant to which Companies listed on the Nasdaq Capital Market (the “Capital Market”) are required to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Capital Market, or (b) either of the alternatives to compliance with the Equity Standard provided under Nasdaq Listing”

Vivos Therapeutics, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“be at least $2,500,000 (the “Minimum Stockholders’ Equity Requirement”). As reported in its Form 10-Q, the Company’s stockholders’ equity as of June 30, 2023 was approximately $2,106,000. The Staff’s notice has no immediate impact on the listing of the Company’s common stock on Nasdaq. In accordance with the Nasdaq Listing Rules, the Company has 45 calendar days,”

Cellectar Biosciences, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 16, 2023, Cellectar Biosciences, Inc. (the “Company”) received notice from Nasdaq which indicated that under Nasdaq Listing Rule 5550(b)(1), the Company is required to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing. In the Company’s Form 10-Q for the period ended June 30, 2023, the Company reported stockholders’ equity was $(467,004). The notice does not have any immediate impact on the listing of the Company’s stock on Nasdaq. In accordance with the Nasdaq Listing Rules, the Company has 45 calendar days, or until September 30, 2023, to submit a plan to r”

MITEK SYSTEMS INC received a nasdaq hearing update notice regarding late filing (rules 5250(c)(1)).

“August 16, 2023, Mitek Systems, Inc. (the "Company") received a decision from the Nasdaq Hearings Panel (the “Panel”) granting the Company’s request for continued listing on the Nasdaq Capital Market, subject to the Company demonstrating compliance with the Nasdaq Listing Rule 5250(c)(1) (the “ Listing Rule”) on or before October 13, 2023, and certain other conditions. As previously disclosed, t he Company received a delisting determination (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff init”

Bright Green Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“August 16, 2023, Bright Green Corporation (the “Company”) received a written notification (the “Notice Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), as the closing bid price for the Company’s common stock was below the $1.00 per share requirement for the last 30 consecutive business days. The Notice Letter stated that the Company has 180 calendar days, or until February 12, 2024 (the “Initial Compliance Period”), to regain compliance with the minimum bid price requirement. If the Company does not rega”

Journey Medical Corp received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 15, 2023, Journey Medical Corporation (the “ Company ” or “ Journey ”) received a deficiency letter (the “ Nasdaq Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on The Nasdaq Capital Market (the “ Stockholders’ Equity Requirement ”), nor is it in compliance with either of the alternative listing standards, market value of listed securities of”

Beard Energy Transition Acquisition Corp. received a nyse deficiency notice notice regarding other (rules 303A.07(c)).

“August 16, 2023, Beard Energy Transition Acquisition Corp. (the “Company”) received a notice from the New York Stock Exchange (the “NYSE”) indicating that the Company was deficient in meeting the requirements of Section 303A.07(c) of the NYSE Listed Company Manual, which required the Company to have, within one year of the Company’s listing on the NYSE, established and maintained an internal audit function. The notice from the NYSE stated that, unless the Company cures this deficiency by August 22, 2023, the Company will be deemed noncompliant. Given the time and focus that the Company is dedi”

Northern Star Investment Corp. IV received a nyse noncompliance notice notice regarding audit committee (rules 303A.07(a)).

“August 17, 2023, the Company received an official notice of non-compliance from the NYSE (the “NYSE Notice”). The NYSE Notice stated that the Company will need to correct the non-compliance as promptly as practicable. It is the intention of the Board to appoint a new independent director, as soon as practicable, who is duly qualified for service on the audit committee and other committees of the Board. 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized”

TuSimple Holdings Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“June 30, 2023 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The Notice indicated that the Company should present its views with respect to this additional deficiency to the Nasdaq Hearings Panel (the “Panel”), which the Company intends to do. The Company expected the Notice, and in June 2023, the Company disclosed to the Panel its plans to file the Form 10-Q by the agreed upon Compliance Date, as described below. As previously disclosed in the Company’s Current Report on Form 8-K filed with the SEC on July 10, 2023, the Company re”

CONX Corp. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“August 14, 2023, the staff of The Nasdaq Stock Market LLC (“Nasdaq”) notified CONX Corp., a Nevada corporation (the “Company”) that it no longer meets Listing Rule 5550(b)(2) (the “Rule”) requiring the Company to maintain a minimum market value of listed securities (“MVLS”) of $35 million. The notice was based on a review of the Company’s MVLS for the past 30 consecutive business days. Nasdaq’s listing rules provide the Company a compliance period of 180 calendar days, or until February 12, 2024, in which to regain compliance. If at any time during this compliance period the Company’s MVLS clo”

FOXO TECHNOLOGIES INC. received a nyse_american deficiency notice notice regarding other (rules 1003(f)(v)).

“August 16, 2023, FOXO Technologies Inc. (the “Company”) received a second written notice (the “Notice”) from the NYSE American LLC (the “NYSE American”) stating that it is not in compliance with the continued listing standard set forth in Section 1003(f)(v) of the NYSE American Company Guide (the “Company Guide”) because the Company’s Class A common stock was selling for a low price per share for a substantial period of time, which NYSE American determined to be a 30-trading day average of less than $0.20 per share. The Notice stated that the Company’s continued listing is predicated on it eff”

Apexigen, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 15, 2023, Apexigen, Inc. (the “Company”) received a written notice from the Listing Qualifications Staff of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, based on the Company’s stockholders’ equity of negative $2.3 million as of June 30, 2023, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, the Company is no longer in compliance with the minimum stockholders’ equity requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(b)(1), which requires companies to maintain stockholders’ equity”

CNS Pharmaceuticals, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 17, 2023, CNS Pharmaceuticals, Inc. (the “Company”) received a letter (the “Letter”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), which notified the Company that it does not presently comply with Nasdaq’s Listing Rule 5550(b)(1) (the “Listing Rule”), which requires that the Company maintain a minimum of $2.5 million in stockholders’ equity, and that the Company also does not meet the alternatives of market value of listed securities or net income from continuing operations set forth in the Listing Rule. The Letter does”